These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 10344046)

  • 21. Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.
    Strong SH; Halperin JL
    Geriatrics; 2007 Mar; 62(3):22-7. PubMed ID: 17346095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of anticoagulant therapy in atrial fibrillation.
    Kottkamp H; Hindricks G; Breithardt G
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S86-96. PubMed ID: 9727682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arkansas Foundation for Medical Care report: preventing stroke in atrial fibrillation.
    Golden WE; Cleves M
    J Ark Med Soc; 1994 Feb; 90(9):439-40. PubMed ID: 8163427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulation: risks and benefits in atrial fibrillation.
    Fiore LD
    Geriatrics; 1996 Jun; 51(6):22-4, 27-8, 31. PubMed ID: 8647473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacoeconomics of atrial fibrillation and stroke prevention.
    Bushnell CD; Matchar DB
    Am J Manag Care; 2004 Apr; 10(3 Suppl):S66-71. PubMed ID: 15152748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
    Gulløv AL; Koefoed BG; Petersen P
    Arch Intern Med; 1999 Jun; 159(12):1322-8. PubMed ID: 10386508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study.
    Lorenzoni R; Lazzerini G; Cocci F; De Caterina R
    Am Heart J; 2004 Jul; 148(1):e6. PubMed ID: 15215815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute management of atrial fibrillation: Part II. Prevention of thromboembolic complications.
    King DE; Dickerson LM; Sack JL
    Am Fam Physician; 2002 Jul; 66(2):261-4. PubMed ID: 12152961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis.
    Andersen LV; Vestergaard P; Deichgraeber P; Lindholt JS; Mortensen LS; Frost L
    Heart; 2008 Dec; 94(12):1607-13. PubMed ID: 18208828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
    Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thromboembolism in atrial fibrillation.
    Menke J; Lüthje L; Kastrup A; Larsen J
    Am J Cardiol; 2010 Feb; 105(4):502-10. PubMed ID: 20152245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
    Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
    J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentré F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Therapie; 2000; 55(6):681-9. PubMed ID: 11234463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Economides Muñoz C; Singh BN
    Minerva Cardioangiol; 2004 Apr; 52(2):125-39. PubMed ID: 15194994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic therapy for stroke prevention among Medicare beneficiaries hospitalized in Alaska with atrial fibrillation.
    Gordian ME; Mustin HD
    Alaska Med; 1998; 40(4):79-84. PubMed ID: 10202404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Frontiers in prevention of thromboembolism in nonvalvular atrial fibrillation].
    Fukunami M
    J Cardiol; 1999 Mar; 33 Suppl 1():65-70. PubMed ID: 10342139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.
    Rockson SG; Albers GW
    J Am Coll Cardiol; 2004 Mar; 43(6):929-35. PubMed ID: 15028346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial fibrillation and stroke prevention.
    Kakar P; Lip GY
    Expert Rev Neurother; 2006 Oct; 6(10):1523-30. PubMed ID: 17078791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.